Litigation Details for BAUSCH HEALTH IRELAND LIMITED v. GLENMARK PHARMACEUTICALS LIMITED (D.N.J. 2019)
✉ Email this page to a colleague
BAUSCH HEALTH IRELAND LIMITED v. GLENMARK PHARMACEUTICALS LIMITED (D.N.J. 2019)
| Docket | ⤷ Sign Up | Date Filed | 2019-05-01 |
| Court | District Court, D. New Jersey | Date Terminated | 2019-09-05 |
| Cause | Assigned To | Renee Marie Bumb | |
| Jury Demand | Referred To | Joel Schneid | |
| Patents | 6,488,962; 6,723,340; 7,780,987; 8,323,692 | ||
| Link to Docket | External link to docket | ||
Details for BAUSCH HEALTH IRELAND LIMITED v. GLENMARK PHARMACEUTICALS LIMITED (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-05-02 | 1 | Complaint | infringement of U.S. Patent Nos. 6,488,962 (the “’962 Patent”), 6,723,340 (the “’340 Patent”), 7,780,987 (… (the “’987 Patent”) and 8,323,692 (the “’692 Patent) (collectively “Patents-in-Suit”) by Defendant Glenmark… of the ’962 Patent and ’340 Patent. 19. On August 4, 2010, the ’987 Patent entitled “Controlled… ’962 Patent and ’340 Patent are listed in Orange Book for Glumetza® 500 mg and the ’987 Patent and the…for infringement of the Patents-in-Suit. This action arises under the Patent Laws of the United States | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
